Navigation Links
AstraZeneca's Rich Fante Elected as National Pharmaceutical Council's Chairman of the Board
Date:10/28/2011

WASHINGTON, Oct. 28, 2011 /PRNewswire-USNewswire/ -- The National Pharmaceutical Council (NPC) today announced that Rich Fante, President, AstraZeneca U.S. and CEO North America, has been elected Chairman of its Board of Directors for 2011-12. Mr. Fante has served on NPC's Board since 2008, most recently as Treasurer.

"Rich takes the helm at a time when the health care landscape is continuing to change at a rapid pace. As someone with tremendous experience in the pharmaceutical industry, Rich understands how NPC's policy research can help inform decision-making among those shaping the future of health care delivery," said NPC President Dan Leonard.

"During my chairmanship, I'm looking forward to leading NPC as it positions itself for the future," said Mr. Fante. "NPC has an important and unique role to play in supporting the development and application of comparative effectiveness research and other data important to improving health outcomes.  By engaging with providers, payers, policymakers and other stakeholders, NPC will be able to meaningfully contribute to shaping the health care environment."

Prior to his current role at AstraZeneca, Mr. Fante served as the company's Vice President, Brand Strategy and Portfolio Operations.  He led the development and execution of marketing strategies for all AstraZeneca brands in the United States.  He has held a number of leadership roles at AstraZeneca, including Vice President—Primary Care for the gastrointestinal and respiratory franchises. Outside of AstraZeneca, Mr. Fante serves as a member of the Roundtable on Value & Science-Driven Health Care for the Institute of Medicine.

Mr. Leonard also recognized the efforts of the outgoing chair, Kevin T. Rigby, Vice President of Public Affairs and Communications at Novartis Pharmaceuticals Corporation, who will remain active on NPC's Board. "Under Kevin's leadership, we made great strides in increasing NPC's awareness and visibility with key CER stakeholders, as well as improving our infrastructure and business operations. We greatly appreciated his involvement in strengthening the organization," said Mr. Leonard.

The NPC Board also elected John Gargiulo, President and CEO of Daiichi Sankyo, Inc., to serve as its Vice Chairman, and Jeff Huth, Senior Vice President, Managed Markets, of Boehringer Ingelheim Pharmaceuticals, Inc., as Treasurer.  

About the National Pharmaceutical Council

The National Pharmaceutical Council is a health policy research organization dedicated to the advancement of good evidence and science, and to fostering an environment in the United States that supports medical innovation. Founded in 1953 and supported by the nation's major research-based pharmaceutical companies, NPC focuses on research development, information dissemination, and education on the critical issues of evidence, innovation and the value of medicines for patients. For more information, visit www.npcnow.org.  


'/>"/>
SOURCE National Pharmaceutical Council
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Thomas Dietz, Ph.D., Elected Chairman of Galleon Pharmaceuticals
2. Prasco® Selected as Eli Lilly and Companys Authorized Generics Partner
3. Prasco Named Exclusive U.S. Distributor for Selected Aspen Branded Products
4. Christine Pierre Selected as "Professional Woman of the Year"
5. Ikaria® CEO Daniel Tasse Elected to PhRMA Board of Directors
6. Dr. Paul Farmer Selected as 2011 Pro Bono Humanum Honoree by Prix Galien USA
7. Coloplast Selected By LifeScience Alley to Host Minnesota Medical Device Panel
8. BioSurplus Selected to Auction $10 Million in Lab Equipment
9. Linet Multicare® Hospital Bed Selected to Participate in National Program Highlighting Commitment to Healthcare Performance Improvement, Innovation
10. Dr. Jay Yadav, CardioMEMS Founder & CEO, Selected as a Finalist for 2011 Business Person of the Year Award
11. Selected Value Therapeutics Exercises Right to Develop and Commercialize ENMD-2076 in China
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... 7, 2016  Lannett Company, Inc. (NYSE: LCI ) ... Markets 2016 Prescription for Success Healthcare Conference on December 14, 2016 ... New York City . In addition, the ... Guggenheim Securities 4 th Annual Boston Healthcare Conference taking place ... ...
(Date:12/6/2016)... , Dec. 6, 2016 Radioisotopes are ... Radioisotopes are produced either by using nuclear research reactor ... the form of alpha, beta or gamma when changed ... are used in Nuclear medicine, specifically in medical diagnostics. ... diagnostic information about a human body,s functioning. Radiotherapy is ...
(Date:12/6/2016)... Dec. 6, 2016 Human Vaccines Market: ... region wise and country wise analysis of the ... manufacturers of human vaccines products, raw material suppliers, ... enter the market. The report provides qualitative ... market. Qualitative analysis comprises market dynamics, trends, product ...
Breaking Medicine Technology:
(Date:12/7/2016)... ... December 07, 2016 , ... “Tomorrow Trump Goes To Washington”: ... greatness back to the presidency and to America. “Tomorrow Trump Goes To Washington” is ... much as she can for this country. , Nancy attributes her patriotic nature to ...
(Date:12/7/2016)... ... 2016 , ... “Fred Rides a Train” allows readers to tag along on ... Rides a Train” is the creation of published author, Janet Morrison, who has been ... Michigan. The "Fred, the Dog" series is her first attempt at writing for children. ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... annual Business Architecture Innovation Summit in Reston, VA on March 21-22, 2017. This ... share a range of experiences from a cross-section of industries such as financial ...
(Date:12/7/2016)... ... December 07, 2016 , ... NuevaCare, a leading home ... is proud to announce new city-specific pages as part of its ambitious website relaunch. ... they often look, first, for local agencies serving their city. The new site has ...
(Date:12/6/2016)... ... 06, 2016 , ... People with Parkinson’s disease and cognitive ... type of MRI, according to a study appearing online in the journal Radiology. ... characterized by tremors or trembling and stiffness in the limbs, impaired balance and ...
Breaking Medicine News(10 mins):